Title

A presumed case of Darbepoetin-induced myocardial infarction in the patient with MDS-RARS

Department

Oncology and Hematology

Document Type

Article

Publication Title

Clinical Case Reports

Abstract

Our case is only the 2nd such reported case of atherothrombosis from ESAs and highlights the increased risk of cardiovascular events in patients receiving erythropoietin-stimulating agents specially patients with underlying MDS where targeting a lower hemoglobin goal and optimizing other cardiovascular risk factors might be beneficial in preventing future cardiovascular mortality.

First Page

658

Last Page

660

DOI

10.1002/ccr3.2728

Publication Date

4-1-2020

Share

COinS